نتایج جستجو برای: vaccine candidate

تعداد نتایج: 216087  

2016
Niyati Khetarpal Ira Khanna

Dengue is a highly endemic infectious disease of the tropical countries and is rapidly becoming a global burden. It is caused by any of the 4 serotypes of dengue virus and is transmitted within humans through female Aedes mosquitoes. Dengue disease varies from mild fever to severe conditions of dengue hemorrhagic fever and shock syndrome. Globalization, increased air travel, and unplanned urban...

Background: Pertussis is still one of the major public health problems. The increase of the disease emerged in recent decades due to the replacement of the reactogenic whole cell vaccine with the safer acellular vaccine and the genetic diversity of the bacterium. As outer membrane vesicles (OMVs) obtained from Bordetella pertussis contains surface immunogenic antigen in its structure, it has an...

2014
Helen McShane Ann Williams

There is an urgent need for an improved TB vaccine. Vaccine development is hindered by the lack of immune correlates and uncertain predictive value of preclinical animal models. As data become available from human efficacy trials, there is an opportunity to evaluate the predictive value of the criteria used to select candidate vaccines. Here we review the efficacy in animal models of the MVA85A...

2017
Charles A. Specht Chrono K. Lee Haibin Huang Maureen M. Hester Jianhua Liu Bridget A. Luckie Melanie A. Torres Santana Zeynep Mirza Payam Khoshkenar Ambily Abraham Zu T. Shen Jennifer K. Lodge Ali Akalin Jane Homan Gary R. Ostroff Stuart M. Levitz

Development of a vaccine to protect against cryptococcosis is a priority given the enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery system, we previously demonstrated that mice vaccinated with crude Cryptococcus-derived alkaline extracts were protected against lethal challenge with Cryptococcus neoformans and Cryptococcus gattii The goal of th...

Maryam Golshani, Saeid Buozari,

Brucellosis caused by species of Brucella is among the most prevalent zoonoses with the annual incidence of half a million cases globally. Most parts of Iran are endemic for brucellosis, and the annual incidence of the human and animal brucellosis is still high. At present, there is no safe and protective human vaccine against brucellosis, and the only preventive strategy is animal vaccination,...

Journal: :PLoS ONE 2009
Julia Romanova Brigitte M. Krenn Markus Wolschek Boris Ferko Ekaterina Romanovskaja-Romanko Alexander Morokutti Anna-Polina Shurygina Sabine Nakowitsch Tanja Ruthsatz Bettina Kiefmann Ulrich König Michael Bergmann Monika Sachet Shobana Balasingam Alexander Mann John Oxford Martin Slais Oleg Kiselev Thomas Muster Andrej Egorov

BACKGROUND We developed a novel intranasal influenza vaccine approach that is based on the construction of replication-deficient vaccine viruses that lack the entire NS1 gene (DeltaNS1 virus). We previously showed that these viruses undergo abortive replication in the respiratory tract of animals. The local release of type I interferons and other cytokines and chemokines in the upper respirator...

2014
Youn-Kyoung Goo Xuenan Xuan

Babesia gibsoni is an intraerythrocytic apicomplexan parasite that causes piroplasmosis in dogs. B. gibsoni infection is characterized clinically by fever, regenerative anemia, splenomegaly, and sometimes death. Since no vaccine is available, rapid and accurate diagnosis and prompt treatment of infected animals are required to control this disease. Over the past decade, several candidate molecu...

Journal: :Genetic Vaccines and Therapy 2005
Ali Azizi Susan Aucoin Helina Tadesse Rita Frost Masoud Ghorbani Catalina Soare Turaya Naas Francisco Diaz-Mitoma

Several studies have shown that cell-mediated immune responses play a crucial role in controlling viral replication. As such, a candidate SARS vaccine should elicit broad CD8+ T-cell immune responses. Several groups of mice were immunized alone or in combination with SARS-nucleocapsid immunogen. A high level of specific SARS-CD8+ T-cell response was demonstrated in mice that received DNA encodi...

2009
Ryan Vander Veen Kurt Kamrud Mark Mogler Alan T. Loynachan Jerry McVicker Peter Berglund Gary Owens Sarah Timberlake Whitney Lewis Jonathan Smith DL Hank Harris

Recombinant hemagglutinin (HA) from a novel H1N1 influenza strain was produced using an alphavirus replicon expression system. The recombinant HA vaccine was produced more rapidly than traditional vaccines, and was evaluated as a swine vaccine candidate at different doses in a challenge model utilizing the homologous influenza A/California/04/2009 (H1N1) strain. Vaccinated animals showed signif...

2014
William J. Weise Meghan E. Hermance Naomi Forrester A. Paige Adams Rose Langsjoen Rodion Gorchakov Eryu Wang Maria D. H. Alcorn Konstantin Tsetsarkin Scott C. Weaver

Mayaro virus (MAYV) is an emerging, mosquito-borne alphavirus that causes a dengue-like illness in many regions of South America, and which has the potential to urbanize. Because no specific treatment or vaccine is available for MAYV infection, we capitalized on an IRES-based approach to develop a live-attenuated MAYV vaccine candidate. Testing in infant, immunocompetent as well as interferon r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید